A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa

Running, not enrolling · Phase 3

Conditions studied: Hidradenitis Suppurativa (HS)

In brief

The purpose of this study is to evaluate long-term safety and efficacy of povorcitinib in participants with moderate to severe hidradenitis suppurativa who completed the 54 weeks of study treatment within the originating parent Phase 3 studies (INCB 54707-301 \[NCT05620823\] or INCB 54707-302 \[NCT05620836\]).

Key facts

Study ID

NCT06212999

Run by

Incyte Corporation

People needed

617

Starts

2024-01-30

Expected to finish

2026-12-26

Last updated by the study team

2026-03-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Completion of the study treatment period of the originating parent study (INCB 54707-301 or INCB 54707-302).
• Agreement to use contraception.
• Willing and able to comply with the study protocol and procedures.
• Further inclusion criteria apply.

You may not qualify if…

• Participation in the extension study could expose the participant to an undue safety risk.
• Women who are pregnant (or who are considering pregnancy) or breastfeeding.
• Further exclusion criteria apply.

Where it is running

• Investigative Site US240 — Scottsdale, Arizona, United States
• Investigative Site US307 — Fort Smith, Arkansas, United States
• Investigative Site US214 — Rogers, Arkansas, United States
• Investigative Site US315 — Laguna Niguel, California, United States
• Investigative Site US223 — Los Angeles, California, United States
• Investigative Site US222 — Oakland, California, United States
• Investigative Site US226 — San Diego, California, United States
• Investigative Site US309 — Clearwater, Florida, United States
• Investigative Site US317 — Hialeah, Florida, United States
• Investigative Site US306 — Hollywood, Florida, United States
• Investigative Site US320 — Hollywood, Florida, United States
• Investigative Site US316 — Maitland, Florida, United States
• Investigative Site US227 — Margate, Florida, United States
• Investigative Site US204 — Miami, Florida, United States
• Investigative Site US236 — Miami, Florida, United States
• Investigative Site US321 — North Miami Beach, Florida, United States
• Investigative Site US200 — Ocala, Florida, United States
• Investigative Site US228 — Tampa, Florida, United States
• Investigative Site US201 — Tampa, Florida, United States
• Investigative Site US311 — Marietta, Georgia, United States
• Investigative Site US220 — West Dundee, Illinois, United States
• Investigative Site US206 — Indianapolis, Indiana, United States
• Investigative Site US337 — Indianapolis, Indiana, United States
• Investigative Site US341 — Bowling Green, Kentucky, United States
• Investigative Site US303 — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.